Z. Nagy

A. Falus, Z. Nagy, C. Balázs, 2000, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Antigen presentation by liposomes: Inhibition with antibodies

J. Klein, Z. Nagy, P. Walden, 1986, European journal of immunology.

Antigen presentation by liposomes.

J. Klein, Z. Nagy, P. Walden, 1985, Haematology and blood transfusion.

Branched polypeptides as antigens for influenza virus hemagglutinin and T-cell receptor subunits.

I. Andó, B. Penke, Z. Nagy, 1993, Peptide research.

Composition of a Suppressor Factor That Inhibits the Immune Response to Lactate Dehydrogenase B

J. Klein, Z. Nagy, P. Walden, 1984, Scandinavian journal of immunology.

Feedback regulation of immune suppression by a suppressor factor

J. Klein, Z. Nagy, Z. Ikezawa, 1984, European journal of immunology.

Surface receptors on lymphoreticular cells: sensory devices for host recognition of foreign antigens and neoplasia.

R. Kerbel, B. Elliott, Z. Nagy, 1980, Canadian Medical Association journal.

Ir-Genes: Quo Usque Tandem?

J. Klein, Z. Nagy, 1983 .

Trouble in the J-land

J. Klein, Z. Nagy, 1982, Nature.

Immunological right of veto

Z. Nagy, 1998, Nature Biotechnology.

Lyt‐Phenotype Conversion of Cytotoxic T Lymphocytes Specific for the A and E Class II Major Histocompatibility Complex Molecules

J. Klein, Z. Nagy, M. Simon, 1983, Scandinavian journal of immunology.

Specific binding of radiolabeled membrane vesicles by T cells activated in the mixed lymphocyte reaction

B. Elliott, Z. Nagy, B. Takács, 1979, European journal of immunology.

Self Tolerance to T Cell Receptor V ~ Sequences By

B. Ober, E. Ward, F. Falcioni, 2003 .

Distribution of alloreactivity among antigen-specific, class II-restricted T-cell clones and hybridomas

J. Klein, T. Nagatani, Z. Nagy, 2004, Immunogenetics.

Lyt phenotypes of primary cytotoxic T cells generated across the A and E region of the H‐2 complex

J. Klein, Z. Nagy, A. Juretić, 1981, European journal of immunology.

Terminal differentiation of T cells specific for mutant H‐2K antigens. Conversion of Lyt‐1,2 cells into Lyt‐2 but not Lyt‐1 cells, in vitro

J. Klein, Z. Nagy, P. Kuśnierczyk, 1981, European journal of immunology.

Antigen Processing: A Reevaluation

J. Klein, Z. Nagy, P. Walden, 1985 .

H-2-controlled suppression of T cell response to lactate dehydrogenase B. Characterization of the lactate dehydrogenase B suppressor pathway

J. Klein, Z. Nagy, N. Ishii, 1982, The Journal of experimental medicine.

Macrophage or T cell - that is the question.

J. Klein, Z. Nagy, 1981, Immunology today.

Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules

J. Guenot, S. Berthel, F. Falcioni, 1999, Nature Biotechnology.

In the mixed lymphocyte reaction.

P. Krammer, B. Elliott, Z. Nagy, 1976 .

Genetics of the major histocompatibility complex: the final act.

J. Klein, F. Figueroa, Z. Nagy, 1983, Annual review of immunology.

The Intricate Behavior of T Cells

Z. Nagy, 2014 .

Antigen capture in chicken spleen during the primary immune response and relationship to phagocytic activity.

Z. Nagy, E. Horváth, Z. Urban, 1973, Nature: New biology.

Design and Synthesis of a Competent Pyrrolinone−Peptide Hybrid Ligand for the Class II Major Histocompatibility Complex Protein HLA-DR1

R. Campbell, Z. Nagy, D. Bolin, 1999 .

Chapter 10 – Autoimmunity

Z. Nagy, 2014 .

Acquired Immunological Tolerance

Z. Nagy, 2014 .

The Antigenic Structure of Lysozyme as Detected by T-cells

E. Appella, L. Adorini, Z. Nagy, 1989 .

Chapter 7 – Antigen Processing and Presentation

Z. Nagy, 2014 .

Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models.

Z. Nagy, F. Schwaiger, E. Rosloniec, 2006, Journal of autoimmunity.

A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules

Z. Nagy, N. Mooney, 2003, Journal of Molecular Medicine.

A hemagglutinin-based multipeptide construct elicits enhanced protective immune response in mice against influenza A virus infection.

E. Rajnavölgyi, Z. Nagy, P. Gogolák, 1998, Immunology letters.

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association

R. Karr, J. Guenot, Z. Nagy, 1995, The Journal of experimental medicine.

Chapter 21. The T Cell – Antigen Presenting Cell Interaction as a Site for Immunosuppressive Interventions

Z. Nagy, D. Vidović, 1995 .

Unique Clinical and Pathological Features in HLA-DRB1*0401–restricted MBP 111–129–specific Humanized TCR Transgenic Mice

S. Ludwin, Roland Martin, H. McFarland, 2004, The Journal of experimental medicine.

G6b-B regulates an essential step in megakaryocyte maturation

Richa Bharti, Sascha Dietrich, B. Nieswandt, 2021, bioRxiv.

The site and stage of anti-DNA B-cell deletion

R. Hardy, M. Radic, S. Camper, 1995, Nature.

The First Victory of Molecular Biology

Z. Nagy, 2014 .

Chapter 3 – Immunological Specificity

Z. Nagy, 2014 .

Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition.

L. Adorini, P. Lehmann, F. Falcioni, 1989, Immunology today.

IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3.

A. Carbone, C. Carlo-Stella, M. Di Nicola, 2007, Cancer research.

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.

A. Steere, B. Huber, Z. Nagy, 1998, Science.

Absence of Ir gene control of T cells recognizing foreign antigen in the context of allogeneic MHC molecules

J. Klein, Z. Nagy, N. Ishii, 1982, Nature.

In vitro correlate for a clonal deletion mechanism of immune response gene-controlled nonresponsiveness

J. Klein, Z. Nagy, N. Ishii, 1983, The Journal of experimental medicine.

Absence of Ir-Gene Control in T-Cell Responses Restricted By Allogeneic Mhc Molecules

J. Klein, Z. Nagy, N. Ishii, 1983 .

Different repertoires of mouse T cells for bovine insulin presented by syngeneic and allogeneic cells

Z. Nagy, J. Klein, Norishisa Ishii, 1983, European journal of immunology.

Ultrastructural localization of Hsp-72 examined with a new polyclonal antibody raised against the truncated variable domain of the heat shock protein.

B. Tombor, J. Prechl, Z. Nagy, 1999, Cell stress & chaperones (Print).

Recessive T cell response to poly (Glu50Tyr50) possibly caused by self tolerance.

J. Klein, Z. Nagy, D. Vidović, 1985, Journal of immunology.

H-2 haplotypes carrying identical D but different L alleles.

J. Klein, F. Figueroa, Z. Nagy, 2008, Tissue antigens.

Haplotype-specific suppression of T cell response to lactate dehydrogenase B in (responder x nonresponder)F1 mice.

J. Klein, Z. Nagy, C. Baxevanis, 1982, Journal of immunology.

Cross-reactivity of suppressor T cells specific for lactate dehydrogenase B and IgG2a myeloma protein.

J. Klein, Z. Nagy, C. Baxevanis, 1983, Journal of immunology.

Ecotin, a microbial inhibitor of serine proteases, blocks multiple complement dependent and independent microbicidal activities of human serum

P. Gál, Z. Nagy, E. Boros, 2019, PLoS pathogens.

Directed Evolution-Driven Increase of Structural Plasticity Is a Prerequisite for Binding the Complement Lectin Pathway Blocking MASP-Inhibitor Peptides

Annamária F. Ángyán, Z. Gáspári, P. Gál, 2022, ACS chemical biology.

Class I restricted interaction between suppressor and cytolytic cells in the response to minor histocompatibility antigens.

H. Rammensee, J. Klein, Z. Nagy, 1984, Journal of immunology.

Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.

J. Klein, Z. Nagy, P. Walden, 1986, The Journal of molecular and cellular immunology : JMCI.

Frequency of responsiveness to the H-Y antigen among the B10.W lines.

J. Klein, Z. Nagy, K. Raška, 1983, Journal of Immunology.

Peptide competition for antigen presentation.

L. Adorini, Z. Nagy, Z. A. Nagy, 1990, Immunology today.

Evidence for two suppressor factors secreted by a single cell suggests a solution to the J-locus paradox.

J. Klein, Z. Nagy, C. Baxevanis, 1983, Proceedings of the National Academy of Sciences of the United States of America.

The role of T cell subsets in the generation of secondary cytolytic responses in vitro against class I and class II major histocompatibility complex antigens.

J. Klein, Z. Nagy, D. Vidović, 1984, Journal of immunology.

Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.

L Raddrizzani, J. Guenot, Z. Nagy, 1997, Journal of immunology.

High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

R. Walsky, Z. Nagy, F. Sinigaglia, 1994, Proceedings of the National Academy of Sciences of the United States of America.

The nature of the interaction between suppressor and helper T cells in the response to LDHB.

J. Klein, Z. Nagy, C. Baxevanis, 1983, Journal of immunology.

Structural requirements for the interaction between peptide antigens and I-Ed molecules.

L Adorini, G Doria, A Sette, 1989, Journal of immunology.

Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing.

E. L. Prak, M. Weigert, Z. Nagy, 1995, Immunity.

Interaction of an immunodominant epitope with Ia molecules in T-cell activation.

L Adorini, G Doria, A Sette, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Antigen-binding receptors on T cells from long-term MLR. Evidence of binding sites for allogeneic and self-MHC products

D. Givol, Y. Ben-Neriah, B. Elliott, 2005, Immunogenetics.

Cytotoxic monoclonal antibody specific for the Lyt-1.2 antigen

J. Klein, F. Figueroa, Z. Nagy, 2004, Immunogenetics.

Receptor specificity, functional characteristics, and cell-surface phenotype of a highly selected anti-I-Ab-specific, long-term T-cell line

B. Elliott, Z. Nagy, H. Wigzell, 1981, Immunogenetics.

Alloactivated Lyt 1 +2− T lymphoblasts bind syngeneic Ia antigens

D. Givol, Y. Ben-Neriah, B. Elliott, 1980, Nature.

Assay for Specific Alloantigen-Binding T Cells Activated in the Mixed Lymphocyte Reaction

B. Elliott, Z. Nagy, M. Nabholz, 1979 .

Conformational and functional properties of peptides covering the intersubunit region of influenza virus hemagglutinin.

G. Fasman, H. Mantsch, B. Penke, 1992, European journal of biochemistry.

Fine specificity analysis of lactate dehydrogenase B‐specific proliferating T cell clones: implications for the mechanism of alloreactivity

J. Klein, Z. Nagy, C. Servis, 1985, European journal of immunology.

Induction of graft versus host-associated immunodeficiency by CD4+ T cell clones.

A. Rolink, P. Lehmann, U. Hurtenbach, 1990, Journal of immunology.

Evolutionary Origin of the Immune System: A Dialogue with Rod Langman

Z. Nagy, 2008, Scandinavian journal of immunology.

294 1D09C3, a human, HLA-DR-specific monoclonal antibody efficiently induces programmed cell death in lymphoid tumors

B. Rattel, Z. Nagy, F. Schwaiger, 2004 .

Two adjacent epitopes on a synthetic dodecapeptide induce lactate dehydrogenase B-specific helper and suppressor T cells

R. Seckler, J. Klein, Z. Nagy, 1986, Proceedings of the Royal Society of London. Series B. Biological Sciences.

Selective in vivo inhibition of T cell activation by class II MHC-binding peptides administered in soluble form.

L. Adorini, S. Muller, Z. Nagy, 1990, Journal of immunology.

Helper effects required during in vivo priming for a cytolytic response to the H-Y antigen in nonresponder mice.

J. Klein, Z. Nagy, A. Juretić, 1985, Journal of immunology.

Self tolerance to T cell receptor V beta sequences

B. Ober, E. Ward, F. Falcioni, 1995, The Journal of experimental medicine.

ORIGIN AND SPECIFICITY OF SURFACE IMMUNOGLOBULIN ON MLR ACTIVATED MOUSE T CELLS

P. Krammer, B. Elliott, Z. Nagy, 1976 .

DESIGN, SYNTHESIS, AND EVALUATION OF A PYRROLINONE-PEPTIDE HYBRID LIGAND FOR THE CLASS II MHC PROTEIN HLA-DR1

R. Campbell, Z. Nagy, D. Bolin, 1998 .

Structural basis for the HLA-DR association of rheumatoid arthritis.

Z. Nagy, F. Sinigaglia, 2001, Current directions in autoimmunity.

Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures.

R Crowther, U. Kammlott, J. Guenot, 2000, Journal of medicinal chemistry.

The Immunological Revolution

Z. Nagy, 2014 .

Rapid Construction and Immunogenicity Testing of a Novel H5 Virus-Like Particle Prototype Vaccine Against Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Virus

Z. Nagy, G. Lovrecz, V. Palya, 2018, Avian Diseases.

Induction of T cell responses in nonresponder mice by abolishing suppression with monoclonal antibodies recognizing A region-controlled, T cell-specific determinants.

J. Klein, R. Abe, Z. Nagy, 1983, Journal of immunology.

In vitro correlate for a clonal deletion mechanism of immune response gene-controlled nonresponsiveness

J. Klein, Z. Nagy, N. Ishii, 1983, The Journal of experimental medicine.

Characterization of “Veto” Cells that Cause Nonresponsiveness to Minor Histocompatibility Antigens

H. Rammensee, J. Klein, Z. Nagy, 1983 .